Skip to main content
DNA Labs India

MEFV Gene Mediterranean fever NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

MEFV Gene Mediterranean fever NGS Genetic Test

Short Name: MEFV Gene NGS Test

Also known as: Familial Mediterranean Fever Genetic Test, FMF Gene Test, MEFV Mutation Analysis, Pyrexin Gene NGS Test, Mediterranean Fever DNA Test

MEFV Gene Mediterranean fever NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS), Sanger Sequencing (for confirmation if required), Bioinformatic Analysis and Variant Interpretation on Blood or Extracted DNA or One Drop Blood on FTA Card samples. Results in 3 to 4 Weeks from the date of sample receipt at the laboratory. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS)All Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to confirm or rule out a diagnosis of Familial Mediterranean Fever by identifying pathogenic or likely pathogenic mutations in the MEFV gene. It enables early diagnosis, appropriate treatment initiation with colchicine, risk assessment for amyloidosis, carrier testing for family members, and genetic counselling for family planning decisions.

Test Code
2161
CPT Code
81479
ICD Code
E85.0
Price
₹20,000
Sample Type
Blood or Extracted DNA or One Drop Blood on FTA Card
Result Time
3 to 4 Weeks from the date of sample receipt at the laboratory
Fasting Required
No
Method
Next Generation Sequencing (NGS), Sanger Sequencing (for confirmation if required), Bioinformatic Analysis and Variant Interpretation
Step 1

Sample Collection

No special preparation or fasting is required. Ensure a detailed clinical history and family pedigree chart are prepared prior to sample collection. A genetic counselling session is recommended before testing.

Method: Venipuncture

Step 2

Laboratory Analysis

A trained phlebotomist will collect approximately 3 mL of venous blood in an EDTA (lavender top) vacutainer using standard venipuncture technique. For FTA card collection, a single drop of blood is placed on the designated area of the card.

Step 3

Report Delivery

Apply pressure to the venipuncture site with a cotton ball for 3–5 minutes. The sample will be transported under appropriate cold chain conditions to the laboratory. No post-collection restrictions are required.

Timeline: 3 to 4 Weeks from the date of sample receipt at the laboratory

Patient Instructions

1
Before the Test:A pre-test genetic counselling session is conducted to review the patient's clinical history, family pedigree, and discuss the implications of testing. No fasting or special preparation is required. Bring any previous medical records, lab results, and a list of current medications.
2
During the Test:A blood sample (approximately 3 mL) is collected by venipuncture into an EDTA tube. The procedure takes about 5–10 minutes and involves minimal discomfort. Alternatively, DNA extracted from a prior sample or blood on an FTA card may be submitted.
3
After the Test:After sample collection, normal activities can be resumed immediately. The sample undergoes DNA extraction, library preparation, NGS sequencing, bioinformatic analysis, and variant interpretation. A post-test counselling session is scheduled to discuss results and their clinical implications.

About This Test

Who Should Get This Test

The purpose of this test is to confirm or rule out a diagnosis of Familial Mediterranean Fever by identifying pathogenic or likely pathogenic mutations in the MEFV gene. It enables early diagnosis, appropriate treatment initiation with colchicine, risk assessment for amyloidosis, carrier testing for family members, and genetic counselling for family planning decisions.

How to Prepare

  • Collect 3 mL of peripheral venous blood in an EDTA vacutainer (lavender top)
  • Alternatively, provide extracted DNA (minimum 50 ng/µL, A260/280 ratio 1.7–2.0) or one drop of blood on an FTA card
  • Clearly label the sample with patient name, date of birth, and unique sample ID
  • Maintain sample at ambient temperature (15–25°C) during transport; do not freeze whole blood
  • Transport sample to the laboratory within 48 hours of collection
  • Include the signed test requisition form and clinical history with the sample

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Familial Mediterranean Fever is frequently underdiagnosed due to symptom overlap with other inflammatory conditions. Genetic testing through NGS provides definitive diagnosis and helps guide long-term management with colchicine therapy. Early diagnosis is critical to prevent amyloidosis-related organ damage, particularly renal amyloidosis, which is the most serious complication of untreated FMF."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One Drop Blood on FTA Card
Sample Volume3 mL
ContainerEDTA (Lavender Top) Vacutainer
Collection MethodVenipuncture

Sample Stability

Whole blood in EDTA: Stable at 15–25°C for up to 72 hours
Extracted DNA: Stable at 2–8°C for up to 1 month; at -20°C for long-term storage
FTA Card: Stable at room temperature for up to 1 year when stored in a sealed bag with desiccant
Sample Rejection Criteria:
  • Hemolyzed, clotted, or insufficient volume blood samples
  • Samples without proper labeling or identification
  • Samples received without signed requisition form
  • Samples transported at improper temperatures or beyond stability window
  • Extracted DNA with A260/280 ratio outside 1.5–2.2 range or concentration below 10 ng/µL

Understanding Your Results

The MEFV Gene NGS Genetic Test results indicate whether pathogenic or likely pathogenic mutations in the MEFV gene have been detected. The interpretation should always be performed in conjunction with clinical findings and family history by a qualified geneticist or treating physician.
📊

Two copies of a pathogenic MEFV variant detected. This result is consistent with a diagnosis of Familial Mediterranean Fever in a symptomatic individual. Clinical correlation is recommended. Initiation of colchicine therapy should be discussed with the treating physician.

Result type: Homozygous Pathogenic Variant

📊

Two different pathogenic MEFV variants detected (one on each allele). This result is consistent with FMF. Phenotype severity may depend on the specific variant combination. Genetic counselling is advised.

Result type: Compound Heterozygous Pathogenic Variants

📊

One pathogenic MEFV variant detected. The individual is a carrier of FMF. Carriers are generally asymptomatic but may occasionally exhibit mild symptoms. Carrier testing of family members is recommended for genetic counselling purposes.

Result type: Heterozygous Pathogenic Variant (Carrier)

📊

A variant in the MEFV gene was detected but its clinical significance is currently unknown. This result alone is not diagnostic of FMF. Clinical correlation, family studies, and periodic reclassification are recommended.

Result type: Variant of Uncertain Significance (VUS)

📊

No known pathogenic variants were identified in the MEFV gene. This result reduces the likelihood of FMF but does not completely exclude it, especially if clinical suspicion remains high. Other genetic or non-genetic causes should be investigated.

Result type: No Pathogenic Variant Detected

⚠️ When to Consult a Doctor:

Consult a rheumatologist or clinical geneticist if you experience recurrent episodes of unexplained fever, abdominal pain, chest pain, joint swelling, or skin rashes lasting 12–72 hours. Seek immediate medical advice if a positive genetic test result is obtained or if there is a known family history of Familial Mediterranean Fever. Early consultation is essential to prevent complications such as amyloidosis.

Limitations

  • This test detects variants only in the MEFV gene and does not screen for mutations in other autoinflammatory disease genes
  • Deep intronic variants, large copy number variations, or structural rearrangements may not be fully detected by standard NGS
  • A negative result does not completely exclude FMF if clinical suspicion remains high; other genes may be involved
  • Variant of uncertain significance (VUS) results require clinical correlation and may need family segregation studies
  • Test performance may be affected by mosaicism at levels below the analytical sensitivity threshold

Risks & Considerations

  • Minor bruising or discomfort at the venipuncture site
  • Very rare risk of fainting during blood draw
  • Psychological impact of genetic test results; genetic counselling is provided to address this
  • Possibility of incidental findings or variants of uncertain significance that may cause anxiety

Interfering Factors

  • Highly degraded DNA may reduce sequencing quality and coverage
  • Recent blood transfusion within the past 4 weeks may affect results due to donor DNA contamination
  • Hemolyzed or improperly stored blood samples may yield insufficient DNA quality
  • Concurrent use of certain medications is unlikely to affect genetic test results but should be disclosed

Compare With Similar Tests

TestMEFV Gene Mediterranean fever NGS Genetic TestMEFV Gene Sanger SequencingTargeted Mutation Panel for FMFWhole Exome Sequencing (WES)C-Reactive Protein (CRP) and ESR Tests
ComparisonMEFV Gene Mediterranean fever NGS Genetic Test

Frequently Asked Questions

What is the MEFV Gene Mediterranean Fever NGS Genetic Test?
The MEFV Gene Mediterranean Fever NGS Genetic Test is a next-generation sequencing based diagnostic test that analyzes the entire coding region of the MEFV gene to identify mutations responsible for Familial Mediterranean Fever (FMF). It provides comprehensive detection of both common and rare pathogenic variants with high accuracy.
Who should get the MEFV Gene NGS Genetic Test?
This test is recommended for individuals experiencing recurrent unexplained episodes of fever with abdominal pain, chest pain, or joint inflammation, those with a family history of FMF, patients of Mediterranean, Middle Eastern, or South Asian ancestry with suggestive symptoms, and family members of confirmed FMF patients for carrier screening.
What is Familial Mediterranean Fever (FMF)?
Familial Mediterranean Fever is a hereditary autoinflammatory disease caused by mutations in the MEFV gene. It is characterized by recurrent episodes of fever, serositis (inflammation of the abdominal, chest, and joint linings), and skin rashes. If untreated, it can lead to amyloidosis and kidney failure. It is most common in individuals of Mediterranean origin.
What sample is required for the MEFV Gene NGS Test?
The test requires either 3 mL of peripheral venous blood collected in an EDTA (lavender top) vacutainer, extracted genomic DNA (minimum 50 ng/µL), or one drop of blood on an FTA card. No fasting is required for sample collection.
How long does it take to receive the test results?
Results for the MEFV Gene NGS Genetic Test are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via online portal, email, and WhatsApp for patient convenience.
What is the cost of the MEFV Gene NGS Genetic Test in India?
The cost of the MEFV Gene Mediterranean Fever NGS Genetic Test at DNA Labs India is Rs 20000. This includes NGS sequencing, bioinformatic analysis, genetic counselling, free home sample collection in select cities, and the clinical test report along with raw data files.
Is genetic testing necessary even if symptoms of FMF are already present?
Yes. While clinical symptoms may suggest FMF, genetic testing is the gold standard for confirming the diagnosis. A definitive molecular diagnosis helps guide appropriate treatment with colchicine, assess the risk of complications like amyloidosis, and enables carrier testing and genetic counselling for family members.
Can this test detect if I am a carrier of FMF?
Yes. The MEFV Gene NGS Test can detect heterozygous carriers who carry one copy of a pathogenic MEFV variant. Carriers are generally asymptomatic but can pass the mutation to their offspring. Carrier testing is particularly valuable for family planning and genetic counselling.
Is the MEFV Gene NGS Test available for children?
Yes. The test can be performed on individuals of all ages, including infants and children. FMF symptoms often begin in childhood, typically before the age of 20. Early diagnosis in children allows for timely initiation of colchicine therapy to prevent complications.
What specific mutations does this test screen for?
The NGS test analyzes the entire coding region and flanking intronic regions of the MEFV gene, covering over 300 known variants including common pathogenic mutations such as M694V, M680I, V726A, M694I, E148Q, and R761H, as well as rare and novel variants. All detected variants are classified according to ACMG/AMP guidelines.
Do I need a doctor's referral for the MEFV Gene NGS Test?
While a physician referral is recommended for optimal clinical context and interpretation, DNA Labs India accepts test requests from patients directly as well. A genetic counselling session is provided as part of the service to ensure proper understanding of the test and its implications.
Does DNA Labs India provide raw genomic data along with the clinical report?
Yes. DNA Labs India is committed to transparency and provides raw data files including FASTQ and VCF files along with the conclusive clinical test report for the MEFV Gene Mediterranean Fever NGS Genetic Test. This allows patients and their physicians to independently review or seek second opinions on the sequencing data.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.